http://owiki.kmu.edu.tw/index.php?action=history&feed=atom&title=Glomerular-vascular_syndrome 2026-04-04T04:18:02Z 本站上此頁的修訂歷史 MediaWiki 1.10.1 http://owiki.kmu.edu.tw/index.php?title=Glomerular-vascular_syndrome&diff=24611&oldid=prev 2018-03-28T05:20:01Z

<p></p> <table border='0' width='98%' cellpadding='0' cellspacing='4' style="background-color: white;"> <tr> <td colspan='2' width='50%' align='center' style="background-color: white;">←上一修訂</td> <td colspan='2' width='50%' align='center' style="background-color: white;">在2018年3月28日 (三) 05:20所做的修訂版本</td> </tr> <tr><td colspan="2" align="left"><strong>第2行：</strong></td> <td colspan="2" align="left"><strong>第2行：</strong></td></tr> <tr><td> </td><td style="background: #eee; font-size: smaller;">**Aging, obesity, hypertension, hyperlipidemia, insulin resistance, smoking, chronic nephrosclerosis, cardiovascular diseases</td><td> </td><td style="background: #eee; font-size: smaller;">**Aging, obesity, hypertension, hyperlipidemia, insulin resistance, smoking, chronic nephrosclerosis, cardiovascular diseases</td></tr> <tr><td> </td><td style="background: #eee; font-size: smaller;">**ApoE gene polymorphism: ApoE4, ApoE2 (lipoprotein nephropathy, esp. Japanese)</td><td> </td><td style="background: #eee; font-size: smaller;">**ApoE gene polymorphism: ApoE4, ApoE2 (lipoprotein nephropathy, esp. Japanese)</td></tr> <tr><td>-</td><td style="background: #ffa; font-size: smaller;">*[[<del style="color: red; font-weight: bold; text-decoration: none;">“Hypertensive”nephrosclerosis</del>]]</td><td>+</td><td style="background: #cfc; font-size: smaller;">*[[<ins style="color: red; font-weight: bold; text-decoration: none;">“Hypertensive” nephrosclerosis</ins>]]</td></tr> <tr><td> </td><td style="background: #eee; font-size: smaller;">*[[Cholesterol emboli (atheroembolic renal disease)]]</td><td> </td><td style="background: #eee; font-size: smaller;">*[[Cholesterol emboli (atheroembolic renal disease)]]</td></tr> <tr><td>-</td><td style="background: #ffa; font-size: smaller;">*Sickle cell disease</td><td>+</td><td style="background: #cfc; font-size: smaller;">*<ins style="color: red; font-weight: bold; text-decoration: none;">[[</ins>Sickle cell disease<ins style="color: red; font-weight: bold; text-decoration: none;">]]</ins></td></tr> <tr><td> </td><td style="background: #eee; font-size: smaller;">*[[Thrombotic microangiopathies]]</td><td> </td><td style="background: #eee; font-size: smaller;">*[[Thrombotic microangiopathies]]</td></tr> <tr><td> </td><td style="background: #eee; font-size: smaller;">*[[Antiphospholipid syndrome]]</td><td> </td><td style="background: #eee; font-size: smaller;">*[[Antiphospholipid syndrome]]</td></tr> <tr><td>-</td><td style="background: #ffa; font-size: smaller;">*ANCA vasculitis</td><td>+</td><td style="background: #cfc; font-size: smaller;">*<ins style="color: red; font-weight: bold; text-decoration: none;">[[</ins>ANCA vasculitis<ins style="color: red; font-weight: bold; text-decoration: none;">]]</ins></td></tr> <tr><td>-</td><td style="background: #ffa; font-size: smaller;">*Henoch-Shönlein purpura</td><td>+</td><td style="background: #cfc; font-size: smaller;">*<ins style="color: red; font-weight: bold; text-decoration: none;">[[</ins>Henoch-Shönlein purpura<ins style="color: red; font-weight: bold; text-decoration: none;">]]</ins></td></tr> <tr><td>-</td><td style="background: #ffa; font-size: smaller;">*Cryoglobulinemia</td><td>+</td><td style="background: #cfc; font-size: smaller;">*<ins style="color: red; font-weight: bold; text-decoration: none;">[[</ins>Cryoglobulinemia<ins style="color: red; font-weight: bold; text-decoration: none;">]]</ins></td></tr> <tr><td>-</td><td style="background: #ffa; font-size: smaller;">*Amyloidosis</td><td>+</td><td style="background: #cfc; font-size: smaller;">*<ins style="color: red; font-weight: bold; text-decoration: none;">[[</ins>Amyloidosis<ins style="color: red; font-weight: bold; text-decoration: none;">]]</ins></td></tr> </table>

Guhjy http://owiki.kmu.edu.tw/index.php?title=Glomerular-vascular_syndrome&diff=24610&oldid=prev 2018-03-28T05:19:19Z

<p></p> <table border='0' width='98%' cellpadding='0' cellspacing='4' style="background-color: white;"> <tr> <td colspan='2' width='50%' align='center' style="background-color: white;">←上一修訂</td> <td colspan='2' width='50%' align='center' style="background-color: white;">在2018年3月28日 (三) 05:19所做的修訂版本</td> </tr> <tr><td colspan="2" align="left"><strong>第1行：</strong></td> <td colspan="2" align="left"><strong>第1行：</strong></td></tr> <tr><td> </td><td style="background: #eee; font-size: smaller;">*Atherosclerotic nephropathy</td><td> </td><td style="background: #eee; font-size: smaller;">*Atherosclerotic nephropathy</td></tr> <tr><td>-</td><td style="background: #ffa; font-size: smaller;">*Aging, obesity, hypertension, hyperlipidemia, insulin resistance, smoking, chronic nephrosclerosis, cardiovascular diseases</td><td>+</td><td style="background: #cfc; font-size: smaller;"><ins style="color: red; font-weight: bold; text-decoration: none;">*</ins>*Aging, obesity, hypertension, hyperlipidemia, insulin resistance, smoking, chronic nephrosclerosis, cardiovascular diseases</td></tr> <tr><td>-</td><td style="background: #ffa; font-size: smaller;">*ApoE gene polymorphism: ApoE4, ApoE2 (lipoprotein nephropathy, esp. Japanese)</td><td>+</td><td style="background: #cfc; font-size: smaller;"><ins style="color: red; font-weight: bold; text-decoration: none;">*</ins>*ApoE gene polymorphism: ApoE4, ApoE2 (lipoprotein nephropathy, esp. Japanese)</td></tr> <tr><td>-</td><td style="background: #ffa; font-size: smaller;">*“Hypertensive”nephrosclerosis</td><td>+</td><td style="background: #cfc; font-size: smaller;">*<ins style="color: red; font-weight: bold; text-decoration: none;">[[</ins>“Hypertensive”nephrosclerosis<ins style="color: red; font-weight: bold; text-decoration: none;">]]</ins></td></tr> <tr><td>-</td><td style="background: #ffa; font-size: smaller;">*Cholesterol emboli (atheroembolic renal disease)</td><td>+</td><td style="background: #cfc; font-size: smaller;">*<ins style="color: red; font-weight: bold; text-decoration: none;">[[</ins>Cholesterol emboli (atheroembolic renal disease)<ins style="color: red; font-weight: bold; text-decoration: none;">]]</ins></td></tr> <tr><td> </td><td style="background: #eee; font-size: smaller;">*Sickle cell disease</td><td> </td><td style="background: #eee; font-size: smaller;">*Sickle cell disease</td></tr> <tr><td>-</td><td style="background: #ffa; font-size: smaller;">*Thrombotic microangiopathies</td><td>+</td><td style="background: #cfc; font-size: smaller;">*<ins style="color: red; font-weight: bold; text-decoration: none;">[[</ins>Thrombotic microangiopathies<ins style="color: red; font-weight: bold; text-decoration: none;">]]</ins></td></tr> <tr><td>-</td><td style="background: #ffa; font-size: smaller;">*Antiphospholipid syndrome</td><td>+</td><td style="background: #cfc; font-size: smaller;">*<ins style="color: red; font-weight: bold; text-decoration: none;">[[</ins>Antiphospholipid syndrome<ins style="color: red; font-weight: bold; text-decoration: none;">]]</ins></td></tr> <tr><td>-</td><td style="background: #ffa; font-size: smaller;">*ANCA vasculitis<del style="color: red; font-weight: bold; text-decoration: none;">, </del>Henoch-Shönlein purpura<del style="color: red; font-weight: bold; text-decoration: none;">, cryoglobulinemia, amyloidosis</del></td><td>+</td><td style="background: #cfc; font-size: smaller;">*ANCA vasculitis</td></tr> <tr><td colspan="2">&nbsp;</td><td>+</td><td style="background: #cfc; font-size: smaller;"><ins style="color: red; font-weight: bold; text-decoration: none;">*</ins>Henoch-Shönlein purpura</td></tr> <tr><td colspan="2">&nbsp;</td><td>+</td><td style="background: #cfc; font-size: smaller;"><ins style="color: red; font-weight: bold; text-decoration: none;">*Cryoglobulinemia</ins></td></tr> <tr><td colspan="2">&nbsp;</td><td>+</td><td style="background: #cfc; font-size: smaller;"><ins style="color: red; font-weight: bold; text-decoration: none;">*Amyloidosis</ins></td></tr> </table>

Guhjy http://owiki.kmu.edu.tw/index.php?title=Glomerular-vascular_syndrome&diff=24609&oldid=prev 2018-03-28T05:17:43Z

<p></p> <table border='0' width='98%' cellpadding='0' cellspacing='4' style="background-color: white;"> <tr> <td colspan='2' width='50%' align='center' style="background-color: white;">←上一修訂</td> <td colspan='2' width='50%' align='center' style="background-color: white;">在2018年3月28日 (三) 05:17所做的修訂版本</td> </tr> <tr><td colspan="2" align="left"><strong>第1行：</strong></td> <td colspan="2" align="left"><strong>第1行：</strong></td></tr> <tr><td>-</td><td style="background: #ffa; font-size: smaller;">*<del style="color: red; font-weight: bold; text-decoration: none;">[[</del>Atherosclerotic nephropathy<del style="color: red; font-weight: bold; text-decoration: none;">]]</del></td><td>+</td><td style="background: #cfc; font-size: smaller;">*Atherosclerotic nephropathy</td></tr> <tr><td>-</td><td style="background: #ffa; font-size: smaller;">*<del style="color: red; font-weight: bold; text-decoration: none;">[[Hypertensive </del>nephrosclerosis<del style="color: red; font-weight: bold; text-decoration: none;">]]</del></td><td>+</td><td style="background: #cfc; font-size: smaller;">*<ins style="color: red; font-weight: bold; text-decoration: none;">Aging, obesity, hypertension, hyperlipidemia, insulin resistance, smoking, chronic </ins>nephrosclerosis<ins style="color: red; font-weight: bold; text-decoration: none;">, cardiovascular diseases</ins></td></tr> <tr><td>-</td><td style="background: #ffa; font-size: smaller;">*<del style="color: red; font-weight: bold; text-decoration: none;">[[</del>Cholesterol emboli<del style="color: red; font-weight: bold; text-decoration: none;">]]</del></td><td>+</td><td style="background: #cfc; font-size: smaller;"><ins style="color: red; font-weight: bold; text-decoration: none;">*ApoE gene polymorphism: ApoE4, ApoE2 (lipoprotein nephropathy, esp. Japanese)</ins></td></tr> <tr><td>-</td><td style="background: #ffa; font-size: smaller;">*<del style="color: red; font-weight: bold; text-decoration: none;">[[</del>Sickle cell disease<del style="color: red; font-weight: bold; text-decoration: none;">]]</del></td><td>+</td><td style="background: #cfc; font-size: smaller;"><ins style="color: red; font-weight: bold; text-decoration: none;">*“Hypertensive”nephrosclerosis</ins></td></tr> <tr><td>-</td><td style="background: #ffa; font-size: smaller;">*<del style="color: red; font-weight: bold; text-decoration: none;">[[</del>Thrombotic microangiopathies<del style="color: red; font-weight: bold; text-decoration: none;">]]</del></td><td>+</td><td style="background: #cfc; font-size: smaller;">*Cholesterol emboli <ins style="color: red; font-weight: bold; text-decoration: none;">(atheroembolic renal disease)</ins></td></tr> <tr><td>-</td><td style="background: #ffa; font-size: smaller;">*<del style="color: red; font-weight: bold; text-decoration: none;">[[</del>Antiphospholipid syndrome<del style="color: red; font-weight: bold; text-decoration: none;">]]</del></td><td>+</td><td style="background: #cfc; font-size: smaller;">*Sickle cell disease</td></tr> <tr><td colspan="2">&nbsp;</td><td>+</td><td style="background: #cfc; font-size: smaller;">*Thrombotic microangiopathies</td></tr> <tr><td colspan="2">&nbsp;</td><td>+</td><td style="background: #cfc; font-size: smaller;">*Antiphospholipid syndrome</td></tr> <tr><td colspan="2">&nbsp;</td><td>+</td><td style="background: #cfc; font-size: smaller;"><ins style="color: red; font-weight: bold; text-decoration: none;">*ANCA vasculitis, Henoch-Shönlein purpura, cryoglobulinemia, amyloidosis</ins></td></tr> </table>

Guhjy http://owiki.kmu.edu.tw/index.php?title=Glomerular-vascular_syndrome&diff=24417&oldid=prev 2018-03-13T09:38:31Z

<p></p> <table border='0' width='98%' cellpadding='0' cellspacing='4' style="background-color: white;"> <tr> <td colspan='2' width='50%' align='center' style="background-color: white;">←上一修訂</td> <td colspan='2' width='50%' align='center' style="background-color: white;">在2018年3月13日 (二) 09:38所做的修訂版本</td> </tr> <tr><td colspan="2" align="left"><strong>第1行：</strong></td> <td colspan="2" align="left"><strong>第1行：</strong></td></tr> <tr><td>-</td><td style="background: #ffa; font-size: smaller;">*<del style="color: red; font-weight: bold; text-decoration: none;">Risk factors</del></td><td>+</td><td style="background: #cfc; font-size: smaller;">*<ins style="color: red; font-weight: bold; text-decoration: none;">[[Atherosclerotic nephropathy]]</ins></td></tr> <tr><td>-</td><td style="background: #ffa; font-size: smaller;">*<del style="color: red; font-weight: bold; text-decoration: none;">*Aging, obesity, insulin resistance, smoking, hypertension, hyperlipidemia</del></td><td>+</td><td style="background: #cfc; font-size: smaller;">*<ins style="color: red; font-weight: bold; text-decoration: none;">[[Hypertensive nephrosclerosis]]</ins></td></tr> <tr><td>-</td><td style="background: #ffa; font-size: smaller;">*<del style="color: red; font-weight: bold; text-decoration: none;">*Apolipoprotein E gene polymorphism</del></td><td>+</td><td style="background: #cfc; font-size: smaller;">*<ins style="color: red; font-weight: bold; text-decoration: none;">[[Cholesterol emboli]]</ins></td></tr> <tr><td>-</td><td style="background: #ffa; font-size: smaller;">*<del style="color: red; font-weight: bold; text-decoration: none;">**Lipoprotein glomerulopathy</del></td><td>+</td><td style="background: #cfc; font-size: smaller;">*<ins style="color: red; font-weight: bold; text-decoration: none;">[[Sickle cell disease]]</ins></td></tr> <tr><td>-</td><td style="background: #ffa; font-size: smaller;">*<del style="color: red; font-weight: bold; text-decoration: none;">CKD patients with GFR&lt;60 mL/min have more cardiovascular events and hospitalizations than those with higher filtration rates</del></td><td>+</td><td style="background: #cfc; font-size: smaller;">*<ins style="color: red; font-weight: bold; text-decoration: none;">[[Thrombotic microangiopathies]]</ins></td></tr> <tr><td>-</td><td style="background: #ffa; font-size: smaller;">*<del style="color: red; font-weight: bold; text-decoration: none;">Approximately 10% of glomeruli are normally sclerotic by age 40, rising to 20% by age 60 and 30% by age 80</del></td><td>+</td><td style="background: #cfc; font-size: smaller;">*<ins style="color: red; font-weight: bold; text-decoration: none;">[[Antiphospholipid syndrome]]</ins></td></tr> </table>

Guhjy http://owiki.kmu.edu.tw/index.php?title=Glomerular-vascular_syndrome&diff=24416&oldid=prev 2018-03-13T09:37:53Z

<p>新頁面: *Risk factors **Aging, obesity, insulin resistance, smoking, hypertension, hyperlipidemia **Apolipoprotein E gene polymorphism ***Lipoprotein glomerulopathy *CKD patients with GFR&lt;60 mL/m...</p> <p><b>新頁面</b></p><div>*Risk factors<br /> **Aging, obesity, insulin resistance, smoking, hypertension, hyperlipidemia<br /> **Apolipoprotein E gene polymorphism<br /> ***Lipoprotein glomerulopathy<br /> *CKD patients with GFR&lt;60 mL/min have more cardiovascular events and hospitalizations than those with higher filtration rates<br /> *Approximately 10% of glomeruli are normally sclerotic by age 40, rising to 20% by age 60 and 30% by age 80</div>

Guhjy